Skip to main content
. 2022 Mar 4;2022:5344508. doi: 10.1155/2022/5344508

Table 3.

Basic information of CS.

Patient ID Age Sex Samples Phenotype
CS1 15 months Male 15 ml cerebrospinal fluid Intracranial space-occupying lesions
CS2 12 months Female 13 ml cerebrospinal fluid Congenital tethered cord syndrome
CS3 17 months Male 15 ml cerebrospinal fluid Intracranial space-occupying lesions
CS4 5 months Male 8 ml cerebrospinal fluid Congenital tethered cord syndrome
CS5 14 months Male 15 ml cerebrospinal fluid Intracranial space-occupying lesions
CS6 22 months Female 15 ml cerebrospinal fluid Congenital tethered cord syndrome
CS7 6 days Male 15 ml cerebrospinal fluid Intracranial hemorrhage
CS8 4 months Male 10 ml cerebrospinal fluid Congenital tethered cord syndrome
CS9 108 months Female 10 ml cerebrospinal fluid Intracranial hemorrhage
CS10 24 months Male 20 ml cerebrospinal fluid Congenital tethered cord syndrome
CS11 36 months Male 8 ml cerebrospinal fluid Intracranial space-occupying lesions
CS12 48 months Male 7 ml cerebrospinal fluid Congenital tethered cord syndrome
CS13 21 months Female 20 ml cerebrospinal fluid Intracranial hemorrhage
CS14 9 days Male 5 ml cerebrospinal fluid Congenital tethered cord syndrome
CS15 72 months Female 12 ml cerebrospinal fluid Congenital tethered cord syndrome
CS16 12 months Female 10 ml cerebrospinal fluid Intracranial hemorrhage
CS17 2 months Male 6 ml cerebrospinal fluid Congenital tethered cord syndrome
CS18 60 months Female 10 ml cerebrospinal fluid Congenital tethered cord syndrome
CS19 20 days Male 20 ml cerebrospinal fluid Congenital tethered cord syndrome
CS20 23 months Female 15 ml cerebrospinal fluid Intracranial space-occupying lesions
CS21 30 months Female 6 ml cerebrospinal fluid Intracranial space-occupying lesions

CS: control subjects.